French Tech 120 - Promotion 2024
Lancé en 2019 par la Mission French Tech, le French Tech Next40/120 est un programme d’accompagnement de l’État dédié aux 120 start-up françaises les plus performantes, en capacité de devenir leaders de rang international. Elles bénéficient pendant un an d’un accompagnement en lien avec leurs enjeux de développement en France et à l’international.
French Tech 120
2024
Aledia
Born from the scientific laboratories of the prestigious CEA, deeptech Aledia is today at the forefront of a technological revolution. After a decade of innovation and development, we are shaping the future of display with our 3D WireLEDTM technology. We aim to be the undisputed global leader in MicroLED for … [voir plus]
AQEMIA
Scale Drug Discovery with Quantum-inspired Physics and AI AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative … [voir plus]
CorWave
CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic … [voir plus]
Devialet
French acoustic engineering. Crafting the future of sound. Devialet is an acoustic engineering technology company, whose goal is to bring high-fidelity sound to the many. Devialet is committed to evolving its technology and product design, without any compromise on sound quality, until everyone can access and enjoy Devialet in every … [voir plus]
DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s … [voir plus]
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, … [voir plus]
Moon Surgical
Moon Surgical développe une plateforme d'assistance à la laparoscopie qui augmente les capacités du chirurgien tout en optimisant l'utilisation des ressources dans le bloc opératoire. [voir plus]
Pasqal
Defining the quantum reality. We build Programmable Quantum Simulators and Quantum Computers made of 2D and 3D Atomic Arrays. Neutral atoms trapped in optical tweezers and addressed with laser beams are ideal indistinguishable quantum systems to realize superposition and entanglement, at the heart of powerful Quantum Information Processing. It is … [voir plus]
PROPHESEE
Metavision Technologies Prophesee is the inventor of the world’s most advanced neuromorphic vision systems. The company developed a breakthrough Event-Based Vision approach to machine vision. This new vision category allows for significant reductions of power, latency and data processing requirements to reveal what was invisible to traditional frame-based sensors until … [voir plus]
SiPearl
Nous concevons le microprocesseur haute performance et basse consommation pour le supercalcul et l'IA. SiPearl conçoit le microprocesseur européen haute performance et basse consommation pour le supercalcul et l'intelligence artificielle. Cette nouvelle génération de microprocesseurs est destinée dans un premier temps à l’écosystème d’EuroHPC, qui déploie en Europe des infrastructures … [voir plus]
TISSIUM
Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, … [voir plus]
TreeFrog Therapeutics
Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant … [voir plus]
Ÿnsect
The world leader in insect ingredient production: a natural, healthy and sustainable solution to feed the world. Ÿnsect is one of world leader in the production of protein and natural insect fertilizers. Founded in 2011 in Paris, France, by both scientists and environmental activists, the company processes insects into high-end, … [voir plus]
Shift Technology
AI-powered insurance decision automation and optimization Shift Technology delivers AI decisioning solutions to benefit the global insurance industry and its customers. Our products enable insurers to automate and optimize decisions from underwriting to claims, resulting in superior customer experiences, increased operational efficiency, and reduced costs. The future of insurance starts … [voir plus]